Η—α

ˆŸ‹}«‰σŽ€«ƒŠƒ“ƒpί‰Š‚ΜƒXƒeƒƒCƒh‰Α—Γ’†‚Ι
‚މŒŒΗ‚Μ‘ˆ«‚΅‚½‚ΖŽv‚ν‚κ‚ιˆκ¬Ž™—α


H@“‘@^—Žq*1@²@“‘@—T@‹v*2@ŠL@X@Œυ@‘ε*3
—с@@@@D*4@ŸN@—с@ˆθ”V‰ξ*5@@@@@@@@

@@@@@@@@@@@@@@@@@@@@@@
A Case of Hyperlipoproteinemia Caused by Corticosteroid Therapy
in a Child with Subacute Necrotizing Lymphadenitis

Mariko KUDOH*1, Hirohisa SATOH*2, Mituomi KAIMORI, MD*3,
Kaori HAYASHI, MD*4 and Ikunosuke SAKURABAYASHI, MD, PhD*5

A 10-year-old child was diagnosed as subacute necrotizing lymphadenitis. After a steroid hormone (predonine) administration for 17 days, he showed total cholesterol(TC) 420mg/dl, triglyceride(TG) 839mg/dl, and LDL-cholesterol 241mg/dl. The hyperlipidemia seemed to be a side effect of the steroid at the onset. However, the lipoprotein fraction by the agarose gel and polyacrylamide gel(PAG) electrophoresis showed type III of the WHO classification, that is, presence of broad band as well as appearance of mid band, small dense-LDL and the disrupted type of LDL band. In addition, there were hyperlipidemia(high levels of the TC, TG, LDL-cholesterol) in 4 persons out of 6 family members, and LDL pattern of the PAG electrophoresis, 4 persons showed the nodular type. They have higher possibility of combined-type familial hyperlipemia from the above results, and it seemed to be the case in which the hyperlipidemia was exacerbated by the steroid administration.
[Rinsho Byori 51 : 419`424, 2003]

*1Department of Clinical Pathology, Aomori Prefectural Central Hospital, Aomori 030-8553

yKey Wordszcorticosteroid therapy(ƒXƒeƒƒCƒhŽ‘—Γ)Cserum lipids(ŒŒ΄Ž‰ŽΏ)Cfamilial combined hyperlipidemia(‰Ζ‘°«•‘‡Œ^‚މŒŒΗ)Csubacute necrotizing lymphadenitis(ˆŸ‹}«‰σŽ€«ƒŠƒ“ƒpί‰Š)

Žσ•t2002”N12ŒŽ6“ϊEŽσ—2003”N4ŒŽ17“ϊ
*1`3ΒXŒ§—§’†‰›•a‰@—Տ°ŒŸΈ•”C*4“―@¬Ž™‰Θ(§030-8553 ΒXŽs“Œ‘’“Ή2-1-1)

E-mail :mako323@infoaomori.ne.jp